Pfizer Announces Strong Profits As New Haven-Based Subsidiary Agrees To Pay False ...

Retrieved on: 2025-02-05 21:08:18

Tags for this article:

Pfizer

Research and development in the United States

Nirmatrelvir/ritonavir

Rimegepant

Biohaven

Click the tags to see associated articles and topics

Pfizer Announces Strong Profits As New Haven-Based Subsidiary Agrees To Pay False .... View article details on hiswai:

Summary

The article highlights Pfizer's significant 2024 profits linked to COVID-19 treatment Paxlovid, despite lower vaccine demand, while addressing a $59 million settlement involving its subsidiary Biohaven's legal violations. The tags relate to Pfizer and connected pharmaceuticals, reflecting on legal and business developments within the company.

Article found on: ctnewsjunkie.com

View Original Article